https://www.selleckchem.com/pr....oducts/fenebrutinib-
, and aids the development of novel therapeutics to control Campylobacter in both veterinary and human populations.Many Gram-negative bacterial pathogens employ translocated virulence factors, termed effector proteins, to facilitate their parasitism of host cells and evade host anti-microbial defenses. However, eukaryotes have evolved to detect effector-mediated virulence strategies through a phenomenon termed effector-triggered immunity (ETI). Although ETI was discovered in plants, a growing body of literature demonstrate
Like
Comment
Share
